Safety study of ORX489 in healthy adults
This phase 1 trial is testing an experimental drug called ORX489 in healthy adults aged 18 to 60. The goal is to see if it is safe and how the body processes it, which helps decide if it can be tried in people with certain conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You are in good general health, with no serious medical conditions
- You have no history of seizures
- You do not have a diagnosed sleep disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called ORX142 in healthy volunteers to see how it is processed by the body. It helps doctors understand the drug's safety before testing in patients.
This trial tests a new drug called ARGX-124 in healthy people to see if it is safe. It is a first step before testing it in patients with certain conditions.
This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.
This trial tests a new medication called BLX-0871 in healthy adults to see how safe it is and how the body processes it. If you are generally healthy and meet the age, weight, and lifestyle requirements, you may be able to join.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This early-stage study tests whether a new oral drug (JMKX003801) is safe in healthy volunteers. It helps find the right dose and checks for side effects.
Hear when a new Healthy Adult Male and Female Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.